Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$26.4 - $30.54 $686,400 - $794,040
-26,000 Reduced 24.46%
80,300 $2.39 Million
Q1 2022

May 13, 2022

BUY
$23.07 - $27.99 $1.48 Million - $1.79 Million
64,000 Added 151.3%
106,300 $2.8 Million
Q4 2021

Feb 15, 2022

BUY
$21.47 - $32.08 $214,700 - $320,800
10,000 Added 30.96%
42,300 $984,000
Q3 2021

Nov 12, 2021

BUY
$23.37 - $32.13 $754,851 - $1.04 Million
32,300 New
32,300 $996,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.84B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.